Free webinar hosted by Protak Scientific Over 50% of the top pharmaceutical companies are already using Enzyme Indicators such as Pfizer, Roche, Sanofi, AstraZeneca, GSK, Novo Nordisk for the production of sterile medicinal products. Protak Scientific are the manufacturer of Enzyme Indicators – the advanced rapid validation tool for measuring hydrogen peroxide bio-decontamination performance. We’re […]
Astra Zeneca champions the advantages of Enzyme Indicators to support cycle optimisation
Protak Scientific celebrate landmark development that is transforming the H202 bio-decontamination and validation process in pharmaceutical aseptic manufacturing The UK based manufacturer supply ‘Enzyme Indicators’ – the unique, advanced rapid validation tool for measuring H2O2 gaseous bio-decontamination performance to many of the largest pharmaceutical names including AstraZeneca, Pfizer, Novo Nordisk, Roche, Bayer, Baxter and […]
We’ll be attending CPHI, at Pennsylvania Convention Center, Philadelphia. CPHI North America is the premier event connecting the entire US pharmaceutical drug development and manufacturing supply chain. As the only pharma event in the Americas region to cover the end-to-end supply chain, we’re looking forward to meeting organisations from every area of the pharma industry […]
Our Protak team will be attending INTERPHEX 2023 at Javits Centre, New York City. The event attracts Industry professionals from pharmaceutical, biotech and device facilities and service providers involved in specifying, recommending or purchasing technologies/products/services for the develop and manufacture of cost effective, quality products.
Protak Athena software launch Protak Scientific is pleased to announce the release of Athena 2.0, our upgraded software for H202 bio-decontamination verification. Athena is the Protak owned software that is used with Enzyme Indicators, an advanced validation tool for measuring decontamination performance instantly – already in use by companies such as Pfizer, Novo Nordisk, Roche […]